Telomerase-activated Au@DNA Nanomachine for Targeted Chemo-photodynamic Synergistic Therapy

Overview

Journal RSC Med Chem

Publisher Royal Society of Chemistry

Specialty Chemistry

Date 2023 Nov 17

PMID 37974961

Authors

Yun-Jie Zhou

Jing Zhang

Dong-Xiao Cao

An-Na Tang

De-Ming Kong

Affiliations

Soon will be listed here.

Abstract

We successfully designed a smart activatable nanomachine for cancer synergistic therapy. Photodynamic therapy (PDT) and chemotherapy can be activated by intracellular telomerase while anti-cancer drugs can be effectively transported into tumour cells. An Sgc8 aptamer was designed, which can specifically distinguish tumour cells from normal cells and perform targeted therapy. The nanomachine entered the tumour cells by recognising PTK7, which is overexpressed on the surface of cancer cells. Then, the "switch" of the system was opened by TP sequence extension under telomerase stimulus. So, the chemotherapeutic drug DOX was released to achieve the chemotherapy, and the Ce6 labelled Sgc8-apt was released to activate the PDT. It was found that if no telomerase existed, the Ce6 would always be in an "off" state and could not activate the PDT. Telomerase is the key to controlling the activation of the PDT, which effectively reduces the damage photosensitisers cause to normal cells. Using and experiments, the nanomachine shows an excellent performance in targeted synergistic therapy, which is expected to be utilised in the future.

References

Zhan M, Ding Y, Huang S, Liu Y, Xiao J, Yu H . Lysyl oxidase-like 3 restrains mitochondrial ferroptosis to promote liver cancer chemoresistance by stabilizing dihydroorotate dehydrogenase. Nat Commun. 2023; 14(1):3123. PMC: 10229567. DOI: 10.1038/s41467-023-38753-6. View

Wu D, Zhao P, Wu L, Lin L, Yu G, Xu L . Aptamer-Functionalized Gold Nanostars for on-Demand Delivery of Anticancer Therapeutics. ACS Appl Bio Mater. 2022; 3(7):4590-4599. DOI: 10.1021/acsabm.0c00499. View

Wang Y, Lin Y, Zhang H, Zhu J . A photodynamic therapy combined with topical 5-aminolevulinic acid and systemic hematoporphyrin derivative is more efficient but less phototoxic for cancer. J Cancer Res Clin Oncol. 2015; 142(4):813-21. DOI: 10.1007/s00432-015-2066-3. View

Yu Z, Hu P, Xu Y, Bao Q, Ni D, Wei C . Efficient Gene Therapy of Pancreatic Cancer via a Peptide Nucleic Acid (PNA)-Loaded Layered Double Hydroxides (LDH) Nanoplatform. Small. 2020; 16(23):e1907233. DOI: 10.1002/smll.201907233. View

Kelland L . The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer. 2007; 7(8):573-84. DOI: 10.1038/nrc2167. View

Issa S, Shaimardanova A, Solovyeva V, Rizvanov A . Various AAV Serotypes and Their Applications in Gene Therapy: An Overview. Cells. 2023; 12(5). PMC: 10000783. DOI: 10.3390/cells12050785. View

Lovell J, Liu T, Chen J, Zheng G . Activatable photosensitizers for imaging and therapy. Chem Rev. 2010; 110(5):2839-57. DOI: 10.1021/cr900236h. View

Noureen N, Wu S, Lv Y, Yang J, Yung W, Gelfond J . Integrated analysis of telomerase enzymatic activity unravels an association with cancer stemness and proliferation. Nat Commun. 2021; 12(1):139. PMC: 7794223. DOI: 10.1038/s41467-020-20474-9. View

Sun R, Liu X, Li G, Wang H, Luo Y, Huang G . Photoactivated H Nanogenerator for Enhanced Chemotherapy of Bladder Cancer. ACS Nano. 2020; 14(7):8135-8148. DOI: 10.1021/acsnano.0c01300. View

10.

Su Z, Xi D, Chen Y, Wang R, Zeng X, Xiong T . Carrier-Free ATP-Activated Nanoparticles for Combined Photodynamic Therapy and Chemotherapy under Near-Infrared Light. Small. 2023; 19(11):e2205825. DOI: 10.1002/smll.202205825. View

11.

Zhu C, Liu P, Li C, Zhang Y, Yin J, Hou L . Near-Death Cells Cause Chemotherapy-Induced Metastasis via ATF4-Mediated NF-κB Signaling Activation. Adv Sci (Weinh). 2023; 10(10):e2205835. PMC: 10074103. DOI: 10.1002/advs.202205835. View

12.

Ghanim G, Fountain A, van Roon A, Rangan R, Das R, Collins K . Structure of human telomerase holoenzyme with bound telomeric DNA. Nature. 2021; 593(7859):449-453. PMC: 7610991. DOI: 10.1038/s41586-021-03415-4. View

13.

Li X, Lee S, Yoon J . Supramolecular photosensitizers rejuvenate photodynamic therapy. Chem Soc Rev. 2018; 47(4):1174-1188. DOI: 10.1039/c7cs00594f. View

14.

Aquilanti E, Kageler L, Watson J, Baird D, Jones R, Hodges M . Telomerase inhibition is an effective therapeutic strategy in TERT promoter-mutant glioblastoma models with low tumor volume. Neuro Oncol. 2023; 25(7):1275-1285. PMC: 10326479. DOI: 10.1093/neuonc/noad024. View

15.

Li X, Cui Y, Du Y, Tang A, Kong D . Label-Free Telomerase Detection in Single Cell Using a Five-Base Telomerase Product-Triggered Exponential Rolling Circle Amplification Strategy. ACS Sens. 2019; 4(4):1090-1096. DOI: 10.1021/acssensors.9b00334. View

16.

Meng H, Hu X, Kong G, Yang C, Fu T, Li Z . Aptamer-functionalized nanoscale metal-organic frameworks for targeted photodynamic therapy. Theranostics. 2018; 8(16):4332-4344. PMC: 6134922. DOI: 10.7150/thno.26768. View

17.

Liu F, Lin J, Luo Y, Xie D, Bian J, Liu X . Sialic acid-targeting multi-functionalized silicon quantum dots for synergistic photodynamic and photothermal cancer therapy. Biomater Sci. 2023; 11(11):4009-4021. DOI: 10.1039/d3bm00339f. View

18.

Cai H, Tan P, Chen X, Kopytynski M, Pan D, Zheng X . Stimuli-Sensitive Linear-Dendritic Block Copolymer-Drug Prodrug as a Nanoplatform for Tumor Combination Therapy. Adv Mater. 2021; 34(8):e2108049. DOI: 10.1002/adma.202108049. View

19.

Li X, Fan H, Guo T, Bai H, Kwon N, Kim K . Sequential Protein-Responsive Nanophotosensitizer Complex for Enhancing Tumor-Specific Therapy. ACS Nano. 2019; 13(6):6702-6710. DOI: 10.1021/acsnano.9b01100. View

20.

Leone R, Powell J . Metabolism of immune cells in cancer. Nat Rev Cancer. 2020; 20(9):516-531. PMC: 8041116. DOI: 10.1038/s41568-020-0273-y. View